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Feasibility of Integrating T. wilfordii into Modern Cancer Therapy for
Increased Efficacy and Minimal Toxicity
Ngoc Vo, Biomedical Engineering – Prof. Mary Boyes, VCU Honors College

Introduction

Findings

• Diseases are becoming more resistance to the drugs that be used in the
market today. Current solution to such problems is to develop strong
and more powerful drugs to combat the disease.
• However, accompanying these powerful drugs are adverse side effects
that is proportional to the effectiveness of the drug.
• According to the CDC, cancer is the second leading cause of death in
the U.S, and the American Cancer Society reported that millions of new
cancer cases are being diagnosed each year.
• Current cancer treatments are chemotherapy and ionizing radiation.
• Adverse effects are hair loss, extraneous damage to healthy cells,
decreased immunity, etc.
• In order to find alternative treatment methods with less side effects,
we turn to Eastern medicine.

Therapeutic Effects of Triptolide
• Inhibits growth of 4 solid tumors (B16 mouse melanoma, MDA-435
human breast cancer, TSU bladder cancer, and MGC80-3 gastric
cancer). Individual effects varies between cell lines, showing cell
specificity (Yang et al.).
• Kiviharju et al. had similar results when studying triptolide in prostatic
epithelial tumors.
• Inhibit vessel formation by nearly 50% at 1.2 μM (He et al.).
• Yang et al. also found that after 3 days of treatment, there was a
significant reduction in proteins and molecules for cell cycle progress.
• Kiviharju et al. found similar results in prostatic cancer cells. Triptolide
increased apoptosis rate slightly after 24h and significantly after 48h.
Therapeutic Effects of Celastrol
• Celastrol cause cell cycle arrest at low concentration and quickly induce
apoptosis at higher concentrations above 800 nM (Peng et al.).
• Peng et al. also found that celastrol increased numbers of cell in G0/G1
starting at concentration of 400 nM.
• Celastrol inhibits VEGF in HUVECs cells at concentration of 1-2 μM
(Pang et al.).

Table 1. Eastern Medicine vs. Western Medicine

Note: From “Consumers’ Perceptions of Chinese Vs. Western Medicine” by Piron, F., Ching, C.,
Peng, E., Ching, H., 2000, Advances in Consumer Research, 27.

• Tripterygium wilfordii, an herbal medicine traditionally used to treat
inflammation in China, contains compounds (triptolide and celastrol)
that prevent the growth of solid tumors, induce apoptosis, and prevent
metastasis of developed tumors.
• Studies of triptolide and celastrol on various cancer cells lines (in vitro
and in vivo) have revealed some information about their mechanism
(mode of action) and toxicity.

Figure 2. Triptolide
(C20H24O6; MW: 360.404)
Figure 1. T. wilfordii
(雷公藤, lei gong teng;
“thunder god vine”)

Figure 3. Celastrol
(C29H38O4; MW: 450.6152)

Synergy
• Other studies have also found that triptolide and celastrol can potentiate
the effects of current cancer treatment (chemotherapy and IR) at low
dosages, thus lessening the adverse effects.
Toxicity & Adverse Effects
• Triptolide causes “severe toxicities towards the gastrointestinal, renal,
cardiac, hepatic, hematopoietic, and reproductive systems” (Liu et al.).
• No adverse reactions have been found to be associated with celastrol.

Conclusion
• Potent drugs are being developed to combat diseases with growing
resistance for current prescription, and adverse effects induced are
proportional to strength of drug.
• The approach taken to rectify this problem is to look for alternative
treatment methods in Eastern medicine. This study is conducted on T.
wilfordii and its anti-cancer effects.
• The bioactive compounds within the plant roots have demonstrated
strong anti-cancer effects, but they can induce detrimental side effects.
• Proposed solution is to use a crude extract of the roots as a treatment
for cancer.
• If the results are undesirable, then research should be taken in the
direction of producing combination drugs containing triptolide and/or
celastrol with selected non-bioactive compounds in the plant.

Proposed Solution
Hypothesis:
Since T. wilfordii is not known to induce the multitude of adverse effects
that triptolide and celastrol has and yet still contains triptolide and
celastrol, T. wilfordii can be an alternative herbal treatment for cancer.
Methods:
• 95% ethanol extract from the roots of T. wilfordii at varying dosages
• In vitro study:
• Measure proliferation of cell, cell vitality, cell survival/cell
apoptosis, and cell cycle arrest. Perform cell toxicity assay.
• In vivo study:
• Injected different cancer cell types into zebrafish and white mice.
• Measure anti-angiogenic property in zebrafish embryos.
• Observe indications of adverse effects in mice. Weekly blood tests
and weighing for 8 weeks.
• Sacrifice mice at the end of the study to examine internal organs.
Should the Experiment Fail:
• If fail in terms of efficacy (and safety), research should turn to natural
products and combination drugs.
• If fails in term of safety alone, then research combinations of herbs that
may have been used with T. wilfordii.
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